Lilly(Eli) & Company
NYSE: LLY
$880.24
-$5.31 (-0.6%)
Real Time Data Delayed 15 Min.
LLY Articles
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang for their buck. There were a couple major IPOs this week that lived up to the hype...
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Animal health company Elanco Animal Health has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin, Philip Morris, Rio Tinto and Spotify.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Published:
Last Updated:
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Published:
Last Updated:
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated: